Neurocytonix, Inc.
NeuroCytonix is a pioneering biomedical technology company dedicated to exploring innovative solutions for brain repair. Their mission is to develop personalized, regenerative medicine aimed at helping the brain heal itself by targeting the root causes of neurological conditions rather than just their effects. They focus on non-invasive radiofrequency protocols to stimulate neurogenesis and neural regeneration, with ongoing research and clinical trials for conditions such as cerebral palsy, autism, stroke, traumatic brain injury, vascular dementia, and the neurological impacts of COVID-19. Their approach involves advanced imaging techniques to monitor brain response and aims to improve the quality of life for individuals with neurological disorders.
Industries
Nr. of Employees
small (1-50)
Neurocytonix, Inc.
2273 Research Boulevard, Suite 725, Rockville, MD, 20850 USA
Products
Non‑invasive RF brain stimulation medical device
A therapeutic enclosure containing emitter arrays and internal magnetic/RF sensors designed to direct low‑energy radiofrequency pulses to localized brain regions for investigational neuroregenerative treatment.
Non‑invasive RF brain stimulation medical device
A therapeutic enclosure containing emitter arrays and internal magnetic/RF sensors designed to direct low‑energy radiofrequency pulses to localized brain regions for investigational neuroregenerative treatment.
Services
Design and conduct of investigator‑led and open‑label studies, randomized controlled trials, patient screening, informed consent management, and trial execution at a clinical research center in Monterrey, Mexico.
Pre‑treatment MRI acquisition and neuroradiological planning to define stimulation targets, followed by on‑site calibration of a medical device to deliver individualized RF dosing.
Pre‑ and post‑treatment imaging assessments including DTI/tractography and volumetry to quantify structural brain changes and correlate imaging biomarkers with clinical outcomes.
Medical eligibility review by neuroradiologists/neurologists, implant/metal safety evaluation using MRI safety principles, and management of inclusion/exclusion criteria.
Design and conduct of investigator‑led and open‑label studies, randomized controlled trials, patient screening, informed consent management, and trial execution at a clinical research center in Monterrey, Mexico.
Pre‑treatment MRI acquisition and neuroradiological planning to define stimulation targets, followed by on‑site calibration of a medical device to deliver individualized RF dosing.
Pre‑ and post‑treatment imaging assessments including DTI/tractography and volumetry to quantify structural brain changes and correlate imaging biomarkers with clinical outcomes.
Medical eligibility review by neuroradiologists/neurologists, implant/metal safety evaluation using MRI safety principles, and management of inclusion/exclusion criteria.
Expertise Areas
- Clinical trial management and execution
- Neuroregenerative therapy development
- Medical device development and calibration for neuromodulation
- Neuroimaging and quantitative image analysis
Key Technologies
- Radiofrequency‑based electromagnetic brain stimulation
- MRI‑guided targeting and treatment planning
- Diffusion tensor imaging (DTI) and tractography
- Volumetric brain analysis and connectivity mapping
News & Updates
Announcement of a new clinical trial to evaluate the protocol's impact on autism spectrum disorder.
Results from a clinical trial assessing the safety and effectiveness of the NeuroCytotron protocol for cerebral palsy.
Announcement of a new clinical trial to evaluate the protocol's impact on autism spectrum disorder.
Results from a clinical trial assessing the safety and effectiveness of the NeuroCytotron protocol for cerebral palsy.